Aescia
Aescia Health: “A continuous-care platform for structured patient follow-up and specialty-clinic workflow. Aescia for Hospitals is an investigational Software as a Medical Device in clinical evaluation through the SAFE-Discharge trial at Royal Prince Alfred Hospital. Aescia for Clinics is a workflow platform for specialty clinics.”
What is Aescia?
“Aescia is a continuous-care platform for the weeks between a high-acuity discharge and the next clinical appointment. It is a privately held healthtech company with operations in Sydney, Australia and Montréal, Canada.”
在公司資料中查看Who founded Aescia?
“Aescia was founded by James Kurrle, a hospital doctor with critical care experience who trained and practised across rural and metropolitan New South Wales (Wagga Wagga and Sydney), and Vasken Dermardiros, a machine-learning PhD from Concordia University. James is the Chief Executive Officer and authors the clinical pathway engine.”
在公司資料中查看When was Aescia founded?
“Aescia was founded in 2025.”
在公司資料中查看Where does Aescia operate?
“Aescia operates from Sydney, Australia and Montréal, Canada. 9550-0708 Québec inc. (NEQ 1181312316) holds the platform intellectual property and does the research and development. Aescia Pty Ltd (ABN 96 687 840 517) operates in Australia and New Zealand and is the Australian regulatory applicant.”
在公司資料中查看